Flash FinanceUS
After hours S&P 5007,520.93-0.38% Nasdaq25,065.88-0.74% Dow 3052,231.89-0.30% Russell 20002,821.38-0.68% Nasdaq-10027,740.79-0.60% MidCap 4003,700.81-0.39% SmallCap 6001,716.22-0.36% VIX19.46-2.31% 10Y Yield4.98+2.45% Close of Nov 10, 2026
AI brief of an SEC Form 8-K · SANUWAVE Health, Inc. (SNWV)

Sanuwave Q3 revenue falls 24% to $8.6 million; swings to operating loss

Negative Impact 4 of 5 earnings

Sanuwave Health reported third-quarter 2026 results on November 10, 2026. Revenue fell 24% to $8.6 million, system sales dropped sharply, and the company posted an operating loss of $1.1 million compared with operating income of $0.9 million a year earlier. Management attributed the weak quarter mainly to a CMS proposed rule, and the prior-year net income of $9.7 million included one-time gains that did not recur.

Key points

  • Q3 2026 revenue was $8.6 million, down 24% from $11.3 million in Q3 2025.
  • Ultramist systems sold: 40 in Q3 2026, versus 155 in Q3 2025 and 82 in Q2 2026.
  • Operating loss of $1.1 million versus operating income of $0.9 million; net loss of $1.4 million versus net income of $9.7 million.
  • Cash and cash equivalents were $6.6 million at September 30, 2026; a business update call is set for November 11, 2026 at 8:30 a.m. EST.

The filing

CompanySANUWAVE Health, Inc. (SNWV)
Form8-K, current report
Filed with the SECNov 10, 2026, 5:09 PM ET
Accession number0001628280-26-072832

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 10, 2026, 6:16 PM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.